- call +1-201-465-4211
- email sales@mrinsights.biz
Lichen sclerosus (LS) is a skin disease of unknown cause, commonly appearing as whitish patches on the genitals, which can affect any body part of any person but has a strong preference for the genitals (penis, vulva) and is also known as balanitis xerotica obliterans (BXO) when it affects the penis. Lichen sclerosus is not contagious. There is a well-documented increase of skin cancer risk in LS, potentially improvable with treatment.
Scope of the Report:
This report studies the Lichen Sclerosus Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lichen Sclerosus Treatment market by product type and applications/end industries.
Topically applied corticosteroids to the LS-affected skin are the first-line treatment for lichen sclerosus in women and men, with strong evidence showing that they are "safe and effective" when appropriately applied, even over long courses of treatment, rarely causing serious adverse effects. They improve or suppress all symptoms for some time, which highly varies across patients, until it is required to use them again. Methylprednisolone aceponate has been used as a safe and effective corticosteroid for mild and moderate cases. For severe cases, it has been theorized that mometasone furoate might be safer and more effective than clobetasol.
The global Lichen Sclerosus Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lichen Sclerosus Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Pfizer
AstraZeneca
Valeant Pharmaceuticals
Sanofi
GlaxoSmithKline
Johnson & Johnson Services
Bristol-Myers Squibb Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Drug Therapy
Surgery
Market Segment by Applications, can be divided into
Hospitals & Clinics
Dermatology Clinics
Pharmacies
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Lichen Sclerosus Treatment Market Overview
1.1 Product Overview and Scope of Lichen Sclerosus Treatment
1.2 Classification of Lichen Sclerosus Treatment by Types
1.2.1 Global Lichen Sclerosus Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Lichen Sclerosus Treatment Revenue Market Share by Types in 2017
1.2.3 Drug Therapy
1.2.4 Surgery
1.3 Global Lichen Sclerosus Treatment Market by Application
1.3.1 Global Lichen Sclerosus Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals & Clinics
1.3.3 Dermatology Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Lichen Sclerosus Treatment Market by Regions
1.4.1 Global Lichen Sclerosus Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Lichen Sclerosus Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lichen Sclerosus Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lichen Sclerosus Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Lichen Sclerosus Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lichen Sclerosus Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Lichen Sclerosus Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Lichen Sclerosus Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Lichen Sclerosus Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Valeant Pharmaceuticals
2.3.1 Business Overview
2.3.2 Lichen Sclerosus Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Valeant Pharmaceuticals Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Lichen Sclerosus Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Lichen Sclerosus Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson Services
2.6.1 Business Overview
2.6.2 Lichen Sclerosus Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Services Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol-Myers Squibb Company
2.7.1 Business Overview
2.7.2 Lichen Sclerosus Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol-Myers Squibb Company Lichen Sclerosus Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Lichen Sclerosus Treatment Market Competition, by Players
3.1 Global Lichen Sclerosus Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Lichen Sclerosus Treatment Players Market Share
3.2.2 Top 10 Lichen Sclerosus Treatment Players Market Share
3.3 Market Competition Trend
4 Global Lichen Sclerosus Treatment Market Size by Regions
4.1 Global Lichen Sclerosus Treatment Revenue and Market Share by Regions
4.2 North America Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
5 North America Lichen Sclerosus Treatment Revenue by Countries
5.1 North America Lichen Sclerosus Treatment Revenue by Countries (2013-2018)
5.2 USA Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
6 Europe Lichen Sclerosus Treatment Revenue by Countries
6.1 Europe Lichen Sclerosus Treatment Revenue by Countries (2013-2018)
6.2 Germany Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
6.4 France Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Lichen Sclerosus Treatment Revenue by Countries
7.1 Asia-Pacific Lichen Sclerosus Treatment Revenue by Countries (2013-2018)
7.2 China Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
7.5 India Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
8 South America Lichen Sclerosus Treatment Revenue by Countries
8.1 South America Lichen Sclerosus Treatment Revenue by Countries (2013-2018)
8.2 Brazil Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Lichen Sclerosus Treatment by Countries
9.1 Middle East and Africa Lichen Sclerosus Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Lichen Sclerosus Treatment Revenue and Growth Rate (2013-2018)
10 Global Lichen Sclerosus Treatment Market Segment by Type
10.1 Global Lichen Sclerosus Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Lichen Sclerosus Treatment Market Forecast by Type (2018-2023)
10.3 Drug Therapy Revenue Growth Rate (2013-2023)
10.4 Surgery Revenue Growth Rate (2013-2023)
11 Global Lichen Sclerosus Treatment Market Segment by Application
11.1 Global Lichen Sclerosus Treatment Revenue Market Share by Application (2013-2018)
11.2 Lichen Sclerosus Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals & Clinics Revenue Growth (2013-2018)
11.4 Dermatology Clinics Revenue Growth (2013-2018)
11.5 Pharmacies Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Lichen Sclerosus Treatment Market Size Forecast (2018-2023)
12.1 Global Lichen Sclerosus Treatment Market Size Forecast (2018-2023)
12.2 Global Lichen Sclerosus Treatment Market Forecast by Regions (2018-2023)
12.3 North America Lichen Sclerosus Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Lichen Sclerosus Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lichen Sclerosus Treatment Revenue Market Forecast (2018-2023)
12.6 South America Lichen Sclerosus Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lichen Sclerosus Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Lichen Sclerosus Treatment Picture
Table Product Specifications of Lichen Sclerosus Treatment
Table Global Lichen Sclerosus Treatment and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
